Who owns the MYRICX BIO trademark?

The MYRICX BIO trademark is owned by Myricx Pharma Limited.

What is the serial number for MYRICX BIO?

The USPTO serial number for MYRICX BIO is 79442817.

What is the registration number for MYRICX BIO?

MYRICX BIO is registered under USPTO registration number 0.

MYR

USPTO Trademark Record

PENDING

MYRICX BIO

Q: What class is the MYRICX BIO trademark registered in?

The MYRICX BIO trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services).

SN 79442817·Reg 0·Filed Aug 06, 2025

Owner Myricx Pharma Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Advertising; business management, organization and administration; office functions.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

MYRICX BIO (Serial No. 79442817), Registration No. 0, is a pending US trademark filed on Aug 06, 2025 by Myricx Pharma Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

MYRICX BIO (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Aug 06, 2025

SERIAL

79442817

REG#

Owner

Applicant

Myricx Pharma Limited

Entity

Not Provided

Address

London Innovation Centre, 20 Water Street,, Canary Wharf London E14 5GX

Country

Attorney

NameAndrea L Calvaruso

Law firm

Andrea L Calvaruso Kelley, Drye & Warren LLP

Docket

024553.

Address

175 Greenwich Street, Three World Trade Center, New York, NY 10007, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateAug 06, 2025

Serial Number79442817

Registration No.0

Status DateOct 08, 2026

Published for OppositionOct 27, 2026

Mark TypeStandard characters

Attorney Docket024553.

Status DescriptionLive and pending, publication issue review complete

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

14 events

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 21, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 30, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 21, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 21, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 21, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Apr 09, 2026

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Mar 26, 2026

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Mar 26, 2026

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Feb 21, 2026

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Feb 20, 2026

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Feb 07, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 06, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Feb 06, 2026

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 05, 2026

SN ASSIGNED FOR SECT 66A APPL FROM IB

MYRICX BIO

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Myricx Pharma Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Andrea L Calvaruso

Industries

USPTO Deadlines

Compare

Resources

Company